publication venue for
- PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design.. 63:2816-2831. 2022
- Akt, 14-3-3, and vimentin mediate a drug-resistant invasive phenotype in diffuse large B-cell lymphoma.. 52:849-864. 2011
- More progress defining the crosstalk between multiple myeloma and mesenchymal stem cells of the bone marrow.. 48:1896-1897. 2007
- Matrix metalloproteinases in multiple myeloma.. 37:273-281. 2000
- Cellular interactions among marrow stromal and normal/neoplastic pre-B- and B-lymphoblastic cells.. 22:205-219. 1996